There is an art to slide management in terms of design and content, and in the indexing of slides in complex and/or long presentations, particularly when backup slides need to be called up virtually instantly (e.g., at FDA Advisory Committee Meetings).

The golden rule about inclusion criteria for clinical trials is to use the minimum number necessary and with the least restrictive ranges possible. Start every protocol without any inclusion criteria, even if 50 trials have previously been done on the product and determine which ones are essential. Each one restricts the potential available pool of patients you can enroll.

Using minimally acceptable criteria for continuing with a product's development facilitates the best business decisions and helps to avoid games being played on prematurely terminating a viable project or prolonging a dying or even dead project.